Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on Basilea Pharmaceutica AG. We currently have 26 research reports from 4 professional analysts.
Date | Source | Announcement |
---|---|---|
07Jan20 09:48 | EQS | Edison Investment Research Limited: Edison issues outlook on Basilea Pharmaceutica (BSLN) |
23Apr19 11:27 | EQS | Basilea Pharmaceutica AG (BSLN-CH): Derazantinib has potential in iCCA and beyond |
28Feb19 12:05 | EQS | Basilea Pharmaceutica AG (BSLN-CH): Cresemba on track, pipeline expanding |
25Jan19 15:18 | EQS | Basilea Pharmaceutica AG (BSLN-CH): Derazantinib to enter combo trial with Roche's Tecentriq |
10Jan19 15:37 | EQS | Basilea Pharmaceutica AG (BSLN-CH): Derazantinib interim data in line with expectations |
10Dec18 06:15 | GNW | Basilea Pharmaceutica AG : Continued strong Cresemba® (isavuconazole) U.S. sales performance triggers CHF 10 million milestone payment to Basilea |
14Nov18 06:15 | GNW | Basilea presents preclinical data on its anticancer drug candidate BAL101553 at EORTC-NCI-AACR symposium |
Share: